Wowu Biomedicine Representative Recruitment
Wu Bio had a campus recruitment for the 2025th year, and on September 23rd, 2024, they released a recruitment notice for the position of sales management trainee/pharmaceutical sales representative. The position of sales management trainee/pharmaceutical sales representative was full-time. The work locations included Shanghai, Beijing, Guangzhou and many other places. The number of recruits was 40. The academic qualifications were required to be full-time junior college or above. The majors were not limited to biology, pharmacy, medicine, marketing, and economic management. In terms of job benefits, the salary was 5 - 30K. There were five insurances and one fund (five insurances during the probation period, accumulation fund), meal allowance, transportation allowance, communication allowance, birthday gift, high temperature allowance, performance bonus, regular physical examination and other benefits. The position could also provide a one-way apprenticeship system, systematic training in sales skills, competitive salary, and a broad personal development platform. In addition, Wubo participated in the autumn human resources exchange conference held in Hall 2 of Deqing International Exhibition Center on October 19th, 2024, hoping to recruit more local talents to facilitate the stable development of enterprises in Deqing. Read more exciting novels for free
Recruitment of a Biomedicine Engineering Teacher at the Medical College of South Jiangxi Province
In the sixth recruitment in 2023, there was a recruitment of high-level talents in the field of biomedicine engineering. The number of people required was two. Doctorate degree and degree were required. The degree of overseas education must be certified by the Education Service Center of the Ministry of Education (2023 graduates can register with valid certificates). The age was based on the age requirements of various types of talents (the age of especially excellent people can be relaxed appropriately). In the recruitment in 2024, the School of Medical Information Engineering was recruiting two teachers of biological engineering. They were required to major in mechanical engineering (0802), instrument science and technology (0804), electronic science and technology (0809), information and communication engineering (0810), control science and engineering (0811), and biological medical engineering (0831 engineering degree). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Tai An Pharmaceutical Representative Recruitment Information
Tai An Pharmaceutical's recruitment information was as follows: - Shandong Renhe Wansheng Pharmaceutical Co., Ltd. is recruiting clinical medicine representatives with a salary of 8,000 - 12,000 yuan. They are required to have 1 - 3 years of work experience and a college degree. - Traditional Chinese Medicine Technology (Xuzhou) Co., Ltd. is recruiting a pharmaceutical representative in Ningyang Hospital. The salary is 5,000 - 9,000 yuan. The requirement is 1 - 3 years of work experience and a bachelor's degree. He is responsible for prescription drug-related work. - Shandong Feixiang Pharmaceutical Technology Co., Ltd. is recruiting a pharmaceutical sales representative in Tai 'an. The salary is 7,000 - 13,000 yuan. The requirements are 1 - 3 years of work experience, college degree, and involved in academic promotion. - Taibang (Beijing) Pharmaceutical Research Institute Co., Ltd. is recruiting Tai 'an-clinical medicine representative (academic promotion). The salary is 15,000 - 20,000 yuan. The requirement is 3 - 5 years of work experience and a bachelor's degree. - Chongqing Winbond Medical Beauty Technology Co., Ltd. is looking for a pharmaceutical representative (provincial manager). The salary is 8,000 - 16,000 yuan. The requirement is 3 - 5 years of work experience, college degree, and responsible for the work related to the Department of Dermatology. - Zhengda Tianqing Pharmaceutical Group Co., Ltd. is looking for a pharmaceutical representative (Tai 'an-comprehensive innovation line)(J14266). The salary is 12,000 - 15,000 yuan. The requirements are 1 - 3 years of work experience and a bachelor's degree. - Zhengda Tianqing Pharmaceutical Group Co., Ltd. is looking for a pharmaceutical representative (Taian-Oncologic Research Line)(J13510). The salary is 12,000 - 15,000 yuan. The requirements are 1 - 3 years of work experience and a bachelor's degree. - Jiangsu Zhiyuan Pharmaceutical Co., Ltd. is looking for a pharmaceutical representative (Tai 'an). The salary is 6,000 - 12,000 yuan. The requirements are 1 - 3 years of work experience, college degree, and related work in regional marketing, academic promotion, medicine, and pharmacy. - Nanjing Fanghua Gene Technology Co., Ltd. is looking for a senior pharmaceutical representative with a salary of 80,000 - 10,000 yuan. The requirement is 1 - 3 years of work experience and a college degree. He is responsible for prescription drugs, in-body diagnosis reagents, and gynecology. - A company is looking for 23JD049-Hospital Manager/Pharmaceutical Representative (Tai 'an, Shandong Province). The salary is 10,000 - 20,000 yuan. The requirement is 1 - 3 years of work experience. The novel "Watching the Moon on Fish Island" is equally exciting. Everyone is welcome to click and read it!
Biomedicine Engineering
In Alibaba.com, positions related to the field of medical engineering, such as medical imaging AI R & D engineer (the job description involves the construction and implementation of medical imaging application products, and requires a bachelor's degree or above in computer science, biomedicine engineering, or related majors). Students who graduated from Zhejiang University's Department of Biomedicine Engineering had joined Ali as development engineers. This showed that biomedicine engineering professionals could get involved in the field of medical and information technology, such as using computer technology to build medical-related applications or platforms. In addition, in Alibaba.com, work related to biomedical-engineering may be related to Aliyun's talent recruitment plan, and there may be more opportunities and different functional changes with the development of Hangzhou's new infrastructure (such as artificial intelligence, 5G, Internet of Things, etc.), such as cross-border from biomedical-engineering to programmer positions related to computer big data. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Zhejiang 2024 Biomedicine News
Here are some of the latest news from Zhejiang in 2024: 1. The final of the 2024 Hangzhou City High-level Talent Creation and Pioneering Competition was held on November 5th at Hangzhou Medical Port in Qiantang (New) District. A total of 1949 applications from more than 30 countries and regions were received, of which 14 projects were selected through layers of selection to compete for four tickets to the finals at Hangzhou Medical Port. The project "First-in- class Small Nucleic Acid Drug for the Treatment of Heterotoluinous Lung Fibrosis" won the first place, which is expected to enter clinical practice in the first half of 2026. In addition, projects such as "Ultra-precise Detection Technology for Spasm Clinic and Intelligent Treatment Robot" won second to fourth place and successfully advanced to the finals. 2. On September 27th, 2024, the first Zhejiang Biomedicine CKO ecological development conference was grandly opened in Zhejiang Province National University Science Park (Linping). This was also an important event of the 2024 Hangzhou International Talent Exchange and Project Cooperation Conference series. The conference focused on the international development of the CXX ecosystem, aiming to promote the deep integration of China's biomedicine industry with the global market. The conference was themed with the theme of "CKO ecological integration: from regional innovation to international cooperation", attracting nearly 300 leading companies and professionals in the field of biomedicine at home and abroad. The Shanghai Technology Exchange's special board for biomedicine, Hangzhou Center, was also officially established at the conference. "The Island of Life" is also a wonderful novel. Everyone is welcome to read it!
Biomedicine Engineering, USA 2022
The following are some of the things that happened in the United States in 2022: - In the 2022nd quarter, the University of virginia's research investment in the field reached 14M, and its research intensity was 140 times that of the original, accounting for a high proportion of all majors. - According to the Bureau of Labor statistics, the average annual salary of a biochemical engineer was $88,500 in 2022, and the employment growth rate was expected to be 7%. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
China-Germany Cooperation in Biomedicine
China and Germany had a wide range of cooperation in the field of biomedicine. In terms of economic and trade cooperation, such as the "Texas (Munchen) economic and trade cooperation promotion conference" held on September 9,2024, Dezhou City and Germany had great potential for cooperation in high-end equipment, sporting goods, high-end textile, biomedicine and many other fields. Both sides looked forward to in-depth cooperation in industry, trade, humanities and other aspects, which also laid a certain economic and trade foundation for cooperation in the field of biomedicine. Judging from the past exchanges and cooperation, the "Discovering Foshan-Global Road Show" and the first China-Germany Health Industry Conference held on April 2,2019 in Main, Germany, promoted the investment environment of Foshan with the theme of biomedicine. The conference gathered many experts, scholars and entrepreneurs in the fields of biomedicine, medical devices, health management, etc., which built an important bridge for the docking and cooperation between Foshan-Germany health industry. Recently, a delegation of German biomedicine companies came to Qiong for an inspection. A delegation composed of representatives of the German Federal Pharmaceutical Association and more than 10 biomedicine companies came to Qiong to seek investment and cooperation opportunities. They were optimistic about the policy advantages and investment opportunities in the field of biomedicine of Hainan Free Trade Port. They conducted field visits and exchanges in key parks such as Hainan National High-tech Industrial Development Zone and Boao Lecheng International Medical tourism Pioneer Zone to discuss the introduction of antibiotics, cloned protein, and innovative drugs and devices. The former chairman of the German Federal Pharmaceutical Association also expressed his expectation to carry out in-depth and diverse cooperation with Hainan to promote the implementation of German innovative medical technology and services in China. In addition, China has also expanded its exchanges and cooperation with Europe, including Germany, in the field of life sciences and medicine through some international exchange activities. For example, the China-Europe Science and Technology Community Themed Day Series and the Second China-Europe Life Science and Medicine Creation Conference held in Lecheng Pioneer Zone on September 15,2024 will further expand the exchanges and cooperation between China, Germany, and Europe in the field of life sciences and medicine, helping Hainan to build a high-level pharmaceutical industry cluster. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Guangxi Medical University Biomedicine
Guangxi Medical University's Department of Biomedicine Engineering was opened in 2009. It was an engineering major, belonging to the Department of Biomedicine Engineering. The school system was four years long, and after graduation, one could obtain a bachelor's degree in engineering. The main courses included Introduction to Basic Medicine, Introduction to clinical medicine, Physics, Advanced Mathematics, and many other courses, such as circuits and electronics, digital circuits and logic design, and other courses related to medical engineering technology. There were also practical courses such as circuit production training, circuit design training, etc. After graduation, he would be able to work in hospitals (institutions), food and drug supervision departments, and enterprises to engage in the maintenance and management of medical instruments, application development, and technical support, as well as the development of hardware and software for computer and network systems in the medical environment, as well as the marketing and after-sales technical services of medical equipment. In 2015, this major became the school's characteristic professional construction point. In 2016, it was awarded the Guangxi innovation and entrepreneur undergraduate higher education reform demonstration major. In 2018, it was approved to be the characteristic professional and experimental training teaching base (center) construction project of Guangxi undergraduate universities. In 2019, it was awarded the first-class undergraduate professional construction point in Guangxi. In 2024, it became a new PhD major. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
How about Jinan Biomedicine?
Jinan's pharmaceutical industry is developing well and has broad prospects. In terms of industrial scale, in 2023, the city's biomedicine and mass health industry realized an operating income of 222.96 billion yuan, more than double the 102.7 billion yuan in 2018. The scale of chemical drugs and biological drugs ranked first in the province. It had excellent performance in the market share of raw materials and preparation products. It had 73 first or exclusive products in the country. For example, the biosimilar drug bevaczhu was the first to be industrialized in the country. From the perspective of policy support, biomedicine has been actively introduced into talents as a key field since 2018. Since 2022, a series of policy documents have been issued, such as "Several policies and measures to accelerate the high-quality development of biomedicine and big health industry" and "Three-year Action Plan for High-quality Development of Jinan City Biomedicine and Big Health Industry (2023 - 2025)". In 2024, there were also constant policy preferences. For example, on June 1, Jinan Medical Security Bureau and other 14 departments jointly issued "Several measures to support the high-quality development of innovative medicine in Jinan City (2024)", which proposed "eight supports" around clinical research, drug and device approval, clinical application, etc., including rewards for the listing of special medical food and medical beauty anti-aging products, as well as subsidies for the listing of enterprises. In terms of enterprise development, Qilu Pharmaceutical, Huaxi Biology, Boke Holdings, Freda, Hongjitang, Yinfeng Biology and other leading enterprises led the way. For example, Qilu Pharmaceutical ranked fifth in the top 100 pharmaceutical industry in the country in 2023 and entered the top 10 in the country for the eighth time. At the same time, it ranked in the forefront of the research and development product line. Moreover, Qilu Pharmaceutical continuously had new drug research and development achievements, such as the self-developed Class 1 new drug, Epalolito Vorelidone, which was approved for marketing. "In terms of industrial layout, Jinan focused on building five characteristic chain groups of biomedicine, traditional Chinese medicine, medical equipment, medical beauty and anti-aging, and special medical food. It built a" 5+1+1 "biomedicine and general health industry system, and formed a cluster ecology of" dual-core, dual-valley and multi-garden "in space. It was led by the" dual-core "of Jinan High-tech Zone and Jinan International Medical Center, and supported by the" dual-valley "of World HA Valley and Luzhong International Bio Valley." Qilu Pharmaceutical Biomedicine Industrial Park and other key parks were "multi-park". <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Kunming to build a biomedicine industry
Kunming has taken many measures to build a biomedicine industry: - ** Industry planning and layout ** - In terms of industrial system construction, Kunming built a "1 + 8 + N" modern industrial system. Biomedicine was one of the eight key industrial chains, and it was developed through "four-wheel drive" such as a strong industrial city. - In terms of spatial layout, the central and southeast regions should strengthen the coordinated development of the industrial parks in the counties and cities and the surrounding cities, focusing on the development of biomedicine and other industries. - ** Enterprise main body ** - By 2023, it had accumulated 361 biomedicine enterprises, covering various types of enterprises such as chemical medicine, traditional Chinese medicine, and biological products. From the perspective of enterprise qualifications, there are 70 high-tech enterprises and 34 specialized and new enterprises; from the perspective of enterprise scale, the number of enterprises with different registered capital levels varies; from the analysis of the number of participants, the number of enterprises in each range of participants also has a corresponding distribution. Moreover, the distribution in each district and county was uneven. There were many enterprises in Wuhua District, Chenggong District, Guandu District, etc. The number of biomedicine enterprises in the top five districts and counties accounted for about 82.43% of the total number of enterprises in the city. - ** In terms of innovation trends ** - From 2016 to 2023, the total number of clinical drug applications was 23 (in terms of varieties), compared with 6 in 2023; the total number of clinical drug applications approved was 44, compared with 5 in 2023; the total number of clinical drug trials was 112, compared with 18 in 2023; the total number of drug applications for marketing was 53, compared with 24 in 2023. - On October 18,2024, the coordination mechanism for clinical trials of drugs and devices in Kunming was established. It was sponsored by the Health and Health Committee of Kunming City and organized by the First People's Hospital of Anning City affiliated to Kunming University of Science and Technology. It aimed to build a communication platform for "production, learning, research and medicine" to discuss the trend of research and development of biomedicine. It would help to improve the level of clinical trials, promote the high-quality development of Kunming's biomedicine industry, reduce research and development time and costs, and accelerate the innovation and listing of drug and device products. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The subjects of the biomedicine researchers included
In the field of biomedicine research, subjects include individuals or groups of people. These people were used to study the causes, diagnosis, treatment, rehabilitation, prognosis, prevention, control, and health maintenance of diseases. For example, in some observational studies or intervention studies, humans were used as subjects, and experimental methods were used to observe and study them in a controlled manner to determine the truth of the hypothesis. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>